eScreen, based in Overland Park, KS, deploys a well-regarded automated platform and FDA-authorized reader for the gathering, handling and reporting of non-regulated and regulated urine drug screens.

Global private equity firm The Carlyle Group today announced it has made an investment in eScreen, Inc., a leading provider of instrumented drug screening and electronic hiring program management ...

Publicly traded Alere Inc. is paying up to $340 million to buy eScreen Inc., a technology company that specializes in toxicology screening and employee health products and services. The purchase price ...

Alere eScreen is expanding in Kansas City, MO with a $6.8 million investment and 30 new jobs. eScreen, Inc., a subsidiary of Alere Inc., is moving its headquarters to Kansas City, MO. In addition to ...

Dr. Murray Lappe had a vision for a paperless drug-screening, designed a process and founded eScreen. Robert Thompson joined him to share that vision as both believed there was more in store for ...

New eScreen eCup+ Drug Testing are available at Lane Regional Medical Center and FASTLane After Hours Urgent Care. Lane has expanded its occupational medicine services by adding eScreen eCup+, which ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. General Manager Chris Tarpey details eScreen’s growth and ...

Medical diagnostics company Alere has entered into an agreement to buy eScreen, Inc., a technology firm that specializes in toxicology screening and employee health products and services, for up to ...

Alere ( ALR), a medical products company focused on integrating rapid diagnostics with health management, recently reported its binding agreement to buy eScreen for a base consideration of $270 ...